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Summary
 
Although interleukin 2 (IL-2) has been thought to be the most important cytokine for T cell
growth, animals lacking IL-2 or a component of its receptor molecules have more expanded T
cells with activated memory phenotype, indicating an indispensable role for the IL-2/IL-2 re-
ceptor system in regulating the size and activity of the T cell population. In this study, we in-
vestigated the possible mechanism of abnormal expansion of activated T cells in IL-2 receptor
 
b
 
 chain (IL-2R
 
b
 
)
 
2
 
/
 
2
 
 mice using the systems of bone marrow transplantation and T cell trans-
 
fer. Here, we show that IL-2R
 
b
 
2
 
/
 
2
 
 T cells in mice reconstituted with a mixture of IL-2R
 
b
 
2
 
/
 
2
 
and IL-2R
 
b
 
1
 
/
 
1
 
 bone marrow cells did not develop into an abnormally activated stage, and that
already activated IL-2R
 
b
 
2
 
/
 
2
 
 T cells were effectively eliminated by IL-2R
 
b
 
1
 
/
 
1
 
 T cells when
both cells were cotransferred to T cell–deficient host mice. This regulation and/or elimination
was dependent on T cells bearing 
 
a
 
/
 
b
 
 type T cell receptor, especially on CD8
 
1
 
 T cells and in-
dependent of the Fas–Fas ligand (FasL) system. IL-2R
 
b
 
1
 
/
 
1
 
 T cells that eliminated activated IL-
2R
 
b
 
2
 
/
 
2
 
 T cells expressed FasL, perforin, granzyme B, and tumor necrosis factor 
 
a
 
/
 
b
 
. These
results indicate a novel function of IL-2R
 
b
 
 that is necessary for the induction of regulatory T
cells acting to eliminate activated T cells.
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I
 
nterleukin (IL)-2 is one of the earliest discovered and
most extensively studied cytokines. It was first character-
ized as a growth factor for T cells, and its main function
was thought to be the induction of T cell proliferation and
expansion (1, 2). Since the discovery of IL-2, the receptor
for IL-2 (IL-2R) has also been extensively studied. IL-2R
is expressed not only in T cells, but also in a wide variety of
hematopoietic cells, including NK cells, B cells, mono-
cytes, and neutrophils. At least three subunit molecules
forming the “IL-2 receptor complex” have been identified
so far. They are designated 
 
a
 
, 
 
b
 
, and 
 
g
 
 chain. 
 
g
 
 chain is
known as 
 
g
 
c (common 
 
g
 
), and works as a subunit of many
different cytokine receptors. 
 
b
 
 chain is also shared with the
receptor for IL-2 and IL-15 (3, 4). The overlapping usage
of the receptor subunits and the expression of the receptor
in various cell types complicate the action of IL-2, and in
consequence, the overall function of IL-2 has not yet been
fully characterized (5, 6).
In this decade, the targeted disruption of genes of inter-
est by homologous recombination has been applied to
mammalian biology and has revealed much information
about the function of hundreds of gene products. Studies of
cytokines have been accelerated by this technique. Mice
disrupted with a gene encoding a cytokine molecule or its
receptor have been created and extensively studied. IL-2
and its receptor are not the exception: IL-2–deficient mice
were first created and described in 1991 (7), followed by
IL-2R
 
a
 
– and 
 
b
 
–deficient mice, both of which were dem-
onstrated in 1995 (8, 9). A striking phenotype of these
gene-targeted mice was the expansion of activated T cells
and autoimmune-like disorders, which might be difficult to
interpret with the previously identified function of the IL-
2/IL-2R system. Some studies on IL-2–deficient mice and
IL-2R
 
a
 
–deficient mice have introduced a possible mecha-
nism to explain the abnormal expansion of activated T cells
in these mice. It was reported earlier that IL-2 is necessary
to induce activation-induced cell death of T cells (10).
Based on this theory, activated T cells produced by stimu-
lation with either self-antigens or nonself-antigens may not
die, but survive long after IL-2 fails to function. Actually, T
cells in IL-2–deficient mice and IL-2R
 
a
 
–deficient T cells
were both shown to be resistant to Fas-mediated activa-
tion-induced cell death (11, 12). In contrast to IL-2– or IL-
2R
 
a
 
–deficient mice, T cells in IL-2R
 
b
 
2
 
/
 
2
 
 mice were 
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b
 
2
 
/
 
2
 
 T Cells
 
shown to be normal in superantigen-induced and Fas-
mediated apoptosis (13). This discrepancy may simply be due
to the involvement of other cytokines, including IL-15,
which uses the IL-2R
 
b
 
 for its receptor component. How-
ever, for a better explanation of abnormal expansion of ac-
tivated T cells in these gene-targeted mice, one must con-
sider another, more important underlying function of the
IL-2/IL-2R systems.
In this study, we investigated the relationship between
IL-2R
 
b
 
2
 
/
 
2
 
 T cells and normal T cells, and found a possible
regulatory activity of normal T cells against IL-2R
 
b
 
2
 
/
 
2
 
 T
cells. We propose here that the most indispensable function
of IL-2R
 
b
 
 is the induction of regulatory T cells, the loss of
which may lead to the abnormalities seen in IL-2R
 
b
 
2
 
/
 
2
 
 mice.
 
Materials and Methods
 
Mice.
 
IL-2R
 
b
 
2
 
/
 
2
 
 mice described previously (9) were main-
tained in our animal facility. All IL-2R
 
b
 
2
 
/
 
2
 
 mice used in this
study had been back-crossed at least 10 times to C57BL/6 (B6)
 
1
 
mice, providing a pure genetic background. These mice were
further crossed with B6/
 
CD45.1/CD45.1
 
 congenic strain to make IL-
2R
 
b
 
2
 
/
 
2
 
 mice with the CD45.1 allotype marker. B6 recombina-
tion activating gene (RAG)-2
 
2
 
/
 
2
 
 (B6.RAG-2
 
2
 
/
 
2
 
) mice were
provided by the Central Institute for Experimental Animals (Ka-
wasaki, Japan) with the permission of Dr. F.W. Alt (Harvard
Medical School, Boston, MA). B6
 
lpr/lpr
 
 mice were purchased
from Japan SLC, Inc. B6
 
gld/gld
 
 mice were provided by Dr. K.
Okumura (Juntendo University, Tokyo, Japan). TCR-
 
b
 
2
 
/
 
2
 
 mice
were provided by Dr. Y. Yoshikai (Nagoya University). Lym-
phocytic choriomeningitis virus (LCMV)-specific TCR trans-
genic mice were provided by Dr. R. Zinkernagel (Institute of
Experimental Immunology, University Hospital, Zürich, Swit-
zerland) and mated with RAG-2
 
2
 
/
 
2
 
 mice to generate TCR
transgenic mice with RAG-2
 
2
 
/
 
2
 
 background.
 
Antibodies and Flow Cytometry.
 
FITC-conjugated anti–mouse
CD69 mAb (clone H1.2F3), PE-conjugated anti-CD62L anti-
body (clone MEL14), FITC- or biotin-conjugated anti-CD45.1
antibody (clone A20), FITC- or biotin-conjugated anti-CD45.2
antibody (clone 104), FITC- or PE-conjugated anti–Thy-1.2 an-
tibody (clone 30-H12), PE-conjugated anti-B220 antibody
(clone RA3-6B2), and FITC-conjugated anti–Gr-1 antibody
(clone RB6-8C5) were purchased from PharMingen. FITC- or
PE-conjugated anti-CD4 antibody (clone H129.19) and FITC-
or PE-conjugated anti-CD8
 
a
 
 antibody (clone 53-6.7) were pur-
chased from Sigma Chemical Co. Cells were stained with anti-
bodies for 20 min on ice, and analyzed using a FACSCalibur™
(Becton Dickinson). Biotin-conjugated antibodies were visual-
ized by secondary staining with streptavidin-conjugated RED670
(GIBCO BRL).
 
Bone Marrow Transplantation.
 
Bone marrow cells were ob-
tained by flushing out the femoral bone marrow of 3-wk-old
mice. In a combination of bone marrow cell preparation, T cells
were depleted by treatment with anti–Thy-1.2 antibody and rab-
bit complement (ICN Pharmaceuticals, Inc.). A total of 2 
 
3
 
 10
 
6
 
bone marrow cells were intravenously injected into an irradiated
(9 Gy) B6.RAG-2
 
2
 
/
 
2
 
 mouse.
 
T Cell Transfer.
 
Lymph node cells from IL-2R
 
b
 
2
 
/
 
2
 
 mice or
spleen cells and lymph node cells from other types of mice were
collected and passed through nylon wool columns. Some of the
nylon wool–passed cells were analyzed before transfer. The re-
maining cells were either mixed or unmixed, and a total of 1–4 
 
3
 
10
 
7
 
 cells were injected intravenously to sublethally irradiated (4
Gy) B6.RAG-2
 
2
 
/
 
2
 
 mice.
 
Purification of Cells Using Magnetic Beads.
 
Spleen and lymph
node cells were stained with biotin-conjugated anti-CD4 or anti-
CD8 antibody, and secondarily incubated with streptavidin mi-
crobeads (MACS; Miltenyi Biotec). The following column work
was performed according to the manufacturer’s protocol (Milte-
nyi Biotec).
 
Reverse-transcribed PCR.
 
RNA was extracted from collected
cells using RNAzol (Tel-Test), and cDNA was created using the
RNA LA PCR kit (Takara). 30 cycles of PCR reaction were
performed under the following conditions: 94
 
8
 
C, 30 s; 60
 
8
 
C, 30 s;
72
 
8
 
C, 90 s. PCR primers used in this study were as follows: 5
 
9
b
 
-actin, TGG AAT CCT GTG GCA TCC ATG AAA C; 3
 
9
b
 
-actin, TAA AAC GCA GCT CAG TAA CAG TCC G; 5
 
9
 
 IL-2,
TGA TGG ACC TAC AGG AGC TCC TGA G; 3
 
9
 
 IL-2, GAG
TCA AAT CCA GAA CAT GCC GCA G; 5
 
9
 
 IL-4, CGA AGA
ACA CCA CAG AGA GTC AGC T; 3
 
9
 
 IL-4, GAC TCA TTC
ATG GTG CAG CTT ATC G; 5
 
9
 
 IFN-
 
g
 
, AGC GGC TGA
CTG AAC TCA GAT TGT AG; 3
 
9
 
 IFN-
 
g
 
, GTC ACA GTT
TTC AGC TGT ATA GGG; 5
 
9
 
 TNF-
 
a
 
, GGC AGG TCT
ACT TTG GAG TCA TTG C; 3
 
9
 
 TNF-
 
a
 
, ACA TTC GAG
GCT CCA GTG AAT TCG G; 5
 
9
 
 TNF-b, TGG CTG GGA
ACA GGG GAA GGT TGA C; 39 TNF-b, CGT GCT TTC
TTC TAG AAC CCC TTG G; 59 Fas ligand (FasL), GGT CAG
CAC TGG TAA GAT TG; 39 FasL, GAG TTC ACC AAC
CAA AGC CT; 59 granzyme B, GCC CAC AAC ATC AAA
GAA CAG; 39 granzyme B, AAC CAG CCA CAT AGC ACA
CAT; 59 perforin, GTC ACG TCG AAG TAC TTG GTG; and
39 perforin, AAC CAG CCA CAT AGC ACA CAT.
Statistical Analysis. The statistical analysis was performed us-
ing StatView J-4.5 software.
Results
IL-2Rb–deficient T Cells in Bone Marrow Chimera Reconsti-
tuted with a Mixture of IL-2Rb1/1 and IL-2Rb2/2 Cells Are
Not Abnormally Activated. To investigate the mechanism
of abnormal development of multiple hematopoietic cells
in IL-2Rb2/2 mice, we first examined bone marrow chi-
meric mice reconstituted with IL-2Rb2/2 bone marrow
cells. When lymphocyte-deficient RAG-22/2 mice were
reconstituted with IL-2Rb2/2 bone marrow cells, T cells
arising from the transferred bone marrow cells later than
6 wk showed a markedly activated memory phenotype of
CD691CD62Llo (Fig. 1, IL-2Rb2/2 BM chimera), CD44hi,
and CD45RBlo (data not shown), all of which were char-
acteristic features of T cells in IL-2Rb2/2 mice (Fig. 1,
IL-2Rb2/2 [9]). These mice also showed phenotypes of
decreased B2201 cells in lymphatic organs, increased Gr-11
cells in bone marrow, and anemia (data not shown), all of
which were observed in IL-2Rb2/2 mice (9), indicating
that most phenotypes caused by IL-2Rb deficiency were
restored by bone marrow reconstitution. However, when
RAG-22/2 mice were reconstituted with a mixture of
IL-2Rb1/1 and IL-2Rb2/2 bone marrow cells, T cells
1Abbreviations used in this paper: B6, C57BL/6; LCMV, lymphocytic
choriomeningitis virus; RAG, recombination activating gene.1563 Suzuki et al.
arising from IL-2Rb2/2 bone marrow cells, which were
distinguished from IL-2Rb1/1–derived cells by CD45 al-
lotype-specific antibody and were shown to exist with a
number similar to that in simple IL-2Rb2/2 bone marrow
chimera, showed no sign of activation (Fig. 1, IL-2Rb1/1 1
IL-2Rb2/2 BM chimera). B cells, granulocytes, and erythro-
cytes were also normal in these mice (data not shown), and
inflammatory bowel disease was never observed. This result
indicates that IL-2Rb2/2 T cells do not develop into an
abnormally activated phenotype when they exist together
with normal IL-2Rb1/1 cells, which may have the activity
to regulate the abnormal activation of IL-2Rb2/2 T cells.
Skewing of IL-2Rb1/1–derived Cells towards CD81 T Cells
in Mixed Bone Marrow Chimeric Mice. In mixed bone mar-
row chimeric mice, the percentages of cells derived from
IL-2Rb1/1 or IL-2Rb2/2 bone marrow were examined
for some different lineage of hematopoietic cells, and the
result was summarized in Table I. Although the bone mar-
row cells of two different mice were mixed at a 1:1 ratio
and were injected into host mice, the ratio of the origin in
differentiated hematopoietic cells in the individual bone
marrow chimeric mice varied. The first striking finding was
the difference in the contribution of IL-2Rb1/1 (or IL-
2Rb2/2) cells between B cells or granulocytes and T cells.
All the mixed bone marrow chimeric mice showed a
higher contribution of IL-2Rb1/1 cells in T cells than in B
cells or granulocytes (i.e., there were more IL-2Rb2/2 cells
in B cells and granulocytes than in T cells). This skewing of T
cells to IL-2Rb1/1 cells was more striking in CD81 T cells
than in CD41 T cells. This difference in CD41 cells and
CD81 cells also reflected the difference in the CD41/
CD81 ratio between IL-2Rb1/1–derived and IL-2Rb2/2–
derived cells. The average ratio was 2.68 for IL-2Rb2/2–
derived cells and 1.25 for IL-2Rb1/1–derived cells. When
bone marrow cells had been depleted with T cells (Table I,
A), or when bone marrow cells from a neonatally thymec-
tomized IL-2Rb2/2 mouse were used (Table I, B), the
skewing was consistently observed, excluding the possibil-
ity of skewing due to the difference in hematopoietic po-
tential influenced by mature T cells infiltrating the bone
marrow.
These profiles of cell origin in mixed bone marrow chi-
meric mice (Table I) are striking, but should be interpreted
carefully. Although we mixed the same numbers of nucle-
ated cells from IL-2Rb2/2 and IL-2Rb1/1 bone marrow,
the frequency of hematopoietic stem cells might have var-
ied in individual donor mice, resulting in the diverse con-
tribution rate of two different donors for individual chi-
meric mice. Skewing of B cells and granulocytes towards
IL-2Rb2/2 cells as a phenotype intrinsic to IL-2Rb2/2
should be excluded for the following reason. In IL-2Rb2/2
mice, the number of granulocytes (Gr-11 cells) is greatly
increased, whereas the number of B2201 cells is markedly
decreased, both of which are secondary phenomena af-
fected by abnormal T cells (9). Therefore, the numbers of
B cells and granulocytes should not have moved in the
same direction when these cells were affected by an IL-
2Rb deficiency. The contribution of host-derived Gr-
11CD45.12 cells could be neglected, because no change
was observed in the CD45.11/CD45.12 ratio in Gr-11
cells compared with that in B2201 cells. With these consid-
erations in mind, we concluded that the IL-2Rb2/2/IL-
2Rb1/1 ratio in B cells and granulocytes reflected the ratio
in hematopoietec stem cells. Accordingly, the skewing of T
cells towards IL-2Rb1/1 cells was a real event, and re-
flected either a decrease in IL-2Rb2/2–derived T cells or
an increase in IL-2Rb1/1–derived T cells.
The CD41/CD81 ratio was also significantly different
between IL-2Rb1/1 and IL-2Rb2/2 cells (Table I). This
difference was mainly caused by a decrease in the CD41/
CD81 ratio in IL-2Rb1/1 cells, because that ratio in mixed
bone marrow chimeric mice was significantly lower than
that in mice simply reconstituted with IL-2Rb1/1 bone
marrow (1.25 6 0.29, n 5 10 vs. 1.84 6 0.22, n 5 5; P ,
0.01, unpaired two group t test), whereas the CD41/CD81
ratio of IL-2Rb2/2 cells in mixed bone marrow chimeric
Figure 1. No abnormal T cell activation in chimeric mice reconsti-
tuted with a mixture of IL-2Rb2/2 and IL-2Rb1/1 bone marrow (BM)
cells. Bone marrow of B6.RAG-22/2 mice was reconstituted with IL-
2Rb1/1 alone (top row), a mixture of IL-2Rb2/2 and IL-2Rb1/1 (sec-
ond row), or IL-2Rb2/2 alone (third row), and their lymph node cells
were analyzed for the expression of CD69 and CD62L. Lymph node cells
obtained from the indicated mice 6 wk after bone marrow transplantation
were stained with a mixture of FITC-conjugated anti-CD69, PE-conju-
gated anti–Thy-1.2, and biotin-conjugated anti-CD45.1 antibodies, or
with a mixture of FITC-conjugated anti–Thy-1.2, PE-conjugated anti-
CD62L, and biotin-conjugated anti-CD45.1 antibodies, then secondarily
stained with streptavidin-conjugated RED670. Bold lines represent the
expression of CD69 or CD62L in cells gated to Thy-1.21CD45.11 pop-
ulation (IL-2Rb2/2–derived T cells). Thin lines represent the expression
in cells gated to Thy-1.21CD45.12 population (IL-2Rb1/1–derived T
cells). The bottom row shows the expression of CD69 and CD62L in T
cells from a 6-wk-old IL-2Rb2/2 mouse.1564 Normal T Cells Eliminate Activated IL-2Rb2/2 T Cells
mice was similar to that in simple IL-2Rb2/2 bone mar-
row chimeric mice (2.68 6 0.46, n 5 10 vs. 2.74 6 0.28,
n 5 5; P . 0.5). Therefore, an especially significant skew-
ing of CD81 T cells to IL-2Rb1/1–derived cells was more
likely to be due to an increase in IL-2Rb1/1 CD81 cells,
rather than to a decrease in IL-2Rb2/2 CD81 cells.
Functional T Cells Are Needed, but Fas/FasL Is Unnecessary
for Regulation of IL-2Rb2/2 T Cells. We performed the
examination of mixed bone marrow chimera using some
different types of mutant mice as partners for IL-2Rb2/2.
As shown in Fig. 2, when bone marrow cells of B6lpr/lpr
mice which lacked the functional Fas molecule were mixed
with IL-2Rb2/2, the resulting IL-2Rb2/2 T cells were
normal in their activation and memory phenotype. Func-
tional FasL-deficient B6gld/gld cells also had the same effect
on the regulation of IL-2Rb2/2 T cells. In contrast with
these Fas/FasL mutant strains, when TCR-b2/2 bone mar-
row cells were mixed with IL-2Rb2/2 and reconstituted
the RAG-22/2 host, the resulting CD41 or CD81 T cells
were all IL-2Rb2/2–derived, and showed a striking acti-
vated phenotype similar to those in IL-2Rb2/2 mice or
simple IL-2Rb2/2 bone marrow chimeras (see Fig. 1). T
cells in LCMV-specific TCR transgenic mice with RAG-
22/2 background, which consequently express TCR mole-
cules with a single specificity, showed no activity to regu-
late the activation of IL-2Rb2/2 T cells (Fig. 2, TCR tg
(RAG-22/2)). All of these chimeric mice were effectively
reconstituted with each partner of bone marrow cells, be-
cause the percentages of mutant partner–derived T cells per
total T cells were not significantly different from those of
mice reconstituted with wild-type B6 and IL-2Rb2/2
bone marrow (P . 0.5 for every combination). Percent-
ages of CD45.12 cells (partners for IL-2Rb2/2) per total T
cells recovered from mixed bone marrow chimera of each
combination were 60.5 6 15.3 (n 5 5), 60.6 6 10.5 (n 5
4), 58.2 6 10.0 (n 5 4), 53.7 6 5.1 (n 5 3), for B6, B6lpr/lpr,
B6gld/gld, and TCR transgenic, respectively, and that of
CD45.12 cells per total B cells was 58.0 6 11.5 (n 5 3) for
TCR-b2/2. These results indicated that functional T cells
with an adequate TCR repertoire were required, but that
Fas or FasL was unnecessary to regulate the abnormal acti-
vation of IL-2Rb2/2 T cells.
Activated IL-2Rb2/2 T Cells Are Eliminated by IL-2Rb1/1
T Cells. To investigate the mechanism of regulation of
IL-2Rb2/2 T cells in more detail, we performed a transfer
of purified T cells to RAG-2–deficient host mice. Nylon
Table I. Granulocytes, B Cells, and T Cell Subsets in Bone Marrow Chimeric Mice Reconstituted with a Mixture of IL-2Rb1/1 and 
IL-2Rb2/2 Cells
Mouse
no.
Source
of BM
Weeks
after BMT
Percentage of CD45.12 (IL-2Rb1/1) cells in CD41/CD81 ratio in
Gr-11 B2201 Thy-11 CD41 CD81 CD45.11 (IL-2Rb2/2) CD45.12 (IL-2Rb1/1)
1 A 4 33.1 27.4 75.7 72.9 80.7 2.35 1.52
2 A 8 27.6 32.8 59.7 48.5 77.5 2.70 0.73
3 B 4 28.3 29.0 51.6 43.5 63.4 3.10 1.39
4 B 8 30.9 24.9 58.7 52.9 66.0 2.68 1.55
5 C 6 22.6 19.2 44.2 34.2 58.0 2.42 0.89
6 C 12 25.9 19.4 44.9 35.4 58.1 2.46 0.97
7 D 6 86.5 80.5 91.9 91.3 93.8 2.00 1.37
8 E 6 19.9 27.6 59.4 50.5 71.1 3.60 1.50
9 E 20 19.4 24.9 47.6 38.6 57.7 2.44 1.13
10 F 32 52.2 42.1 71.6 68.3 78.3 3.06 1.42
Ave. 1–10 10.6 34.6 32.8 60.5 53.6 70.5 2.68 1.25
11 D 12 81.4 84.6 94.3 ND ND ND ND
12 E 20 18.2 16.2 51.8 ND ND ND ND
13 G 4 53.1 49.2 80.4 ND ND ND ND
14 G 6 48.5 51.7 76.5 ND ND ND ND
15 G 8 48.1 49.2 73.2 ND ND ND ND
Ave. 1–15 10.4 39.7 38.6 65.4 – – – –
B6.RAG-22/2 mice were reconstituted with a mixture of IL-2Rb1/1 (CD45.12) and IL-2Rb2/2 (CD45.11) bone marrow (BM) cells. Seven dif-
ferent combinations (A–G) of individual donor mice were used as the source of bone marrow cells. T cells in bone marrow A were depleted before
transplantation, and the IL-2Rb2/2 mouse for the source of bone marrow B had been thymectomized to avoid the infiltration of abnormal T cells
into the bone marrow. At the indicated periods after bone marrow transplantation (BMT), bone marrow cells and lymph node cells from chimeric
mice were analyzed by antibody staining and flow cytometry. Bone marrow cells were stained with anti–Gr-1 and anti-CD45.1 antibodies. Lymph
node cells were stained with anti–Thy-1, anti-B220, and anti-CD45.1 antibodies, or anti-CD4, anti-CD8, and anti-CD45.1 antibodies. Averages
(Ave.) of mice nos. 1–10 and 1–15 are demonstrated separately.1565 Suzuki et al.
wool column–passed lymph node cells (Thy-11 cells .
90%) from IL-2Rb1/1 and IL-2Rb2/2 mice were mixed
with 1:1 ratio (Fig. 3, top middle panel) and transferred to
RAG-22/2 mice. Here, we used IL-2Rb2/2 mice .6 wk,
and almost all T cells from these mice were expressing acti-
vated memory phenotypes with CD691 and CD62Llo (see
Fig. 1). 7 d later, cells were recovered from the spleen and
lymph nodes, and their origin was examined. As shown in
the middle panels of Fig. 3, recovered IL-2Rb2/2 T cells
were much fewer than IL-2Rb1/1 T cells. This phenome-
non was consistently observed because the percentage of
CD45.11 (IL-2Rb2/2) cells per total T cells was 2.6 6
1.1% (n 5 10, from five independent experiments). When
IL-2Rb1/2CD45.11 T cells and IL-2Rb1/1CD45.12 T
cells were mixed and transferred to the RAG-22/2 host, no
increase or decrease in either population was observed 7 d
after transfer (data not shown), excluding the possibility
that IL-2Rb1/1 T cells reacted to CD45.1 antigen, Neor
gene product, or some minor antigenic differences which
had been carried from embryonic stem cells and had not
been eliminated by back-crossing to B6 mice. In the recov-
ered IL-2Rb1/1 T cells that had been transferred with IL-
2Rb2/2 T cells, the CD4/CD8 ratio was skewed towards a
CD81 dominant phenotype (Fig. 3, bottom panels),
whereas no such skewing was observed in IL-2Rb1/1 T
cells simply transferred to RAG-22/2 hosts without IL-
2Rb2/2 T cells. The CD41/CD81 ratio of IL-2Rb1/1
cells recovered from mice transferred with a mixture of IL-
2Rb1/1 and IL-2Rb2/2 T cells was significantly lower
(0.96 6 0.27, n 5 10, from five independent experiments;
P , 0.001, unpaired two group t test) than that of donor
IL-2Rb1/1 mice (1.85 6 0.14, n 5 5), whereas that from
mice transferred with single IL-2Rb1/1 T cells was not
(1.69 6 0.36, n 5 4, from four independent experiments;
P . 0.3).
Analyses of mice at several different time points after T
cell transfer revealed that the change in the IL-2Rb2/2/IL-
2Rb1/1 cell ratio was gradually taking place in vivo in the
initial 6–7 d after T cell transfer to RAG-22/2 host mice
(Fig. 4). At time points later than 7 d, the IL-2Rb2/2/IL-
2Rb1/1 cell ratio was consistently low and not significantly
changed from that of day 7 (data not shown). These results
suggested that normal IL-2Rb1/1 T cells had the activity
to eliminate abnormally activated IL-2Rb2/2 T cells.
IL-2Rb2/2 T Cell Elimination Activity Is Fas–FasL Inde-
pendent, and Stronger in CD81 T Cells. T cells from some
different types of mutant mice were used for the partner of
IL-2Rb2/2 T cells, and were transferred to RAG-22/2
mice. 7 d later, recovered cells were analyzed for their ori-
gin, and percentages of recovered cell numbers per trans-
ferred cell numbers were calculated. As shown in Fig. 5, T
cells from B6lpr/lpr mice and B6gld/gld mice showed an almost
identical action to B6 T cells in eliminating IL-2Rb2/2 T
cells. On the other hand, T cells from LCMV-specific
TCR transgenic mice with RAG-22/2 background showed
no such elimination activity. When normal T cells were
separated into CD41 cells and CD81 cells, and their activ-
ity was measured independently, CD81 cells showed a sig-
nificantly stronger effect than total T cells or CD41 T cells
alone. Interestingly, CD81 T cells showed a markedly in-
creased recovery rate when CD81 T cells were purified
and transferred with IL-2Rb2/2 T cells.
T Cells Eliminating IL-2Rb2/2 T Cells Express TNFs,
FasL, Granzyme B, and Perforin. Our study of mixed T
cell transfer showed an elimination of IL-2Rb2/2 T cells
by normal T cells, and an especially strong elimination ac-
tivity in CD81 T cells suggested a cytotoxic mechanism in
this process. Accordingly, we next examined the expression
of genes involved in T cell cytotoxic activity. T cells,
Figure 2. Requirement of functional a/b TCR but not Fas–FasL for
T cells to regulate the activation of IL-2Rb2/2 T cells. B6.RAG-22/2
mice were reconstituted with a mixture of bone marrow cells from IL-
2Rb2/2 mice and B6, B6lpr/lpr, B6gld/gld, and TCR transgenic (tg) mice
with RAG-22/2 background or TCR-b2/2 mice. Lymph node cells ob-
tained from chimeric mice 6 wk after bone marrow transplantation were
analyzed. The staining procedure was the same as that in the legend to
Fig. 1, except that FITC- or PE-conjugated anti-CD4 and anti-CD8 an-
tibodies were used instead of anti–FITC- or PE-conjugated anti–Thy-1.2
antibody. Bold lines represent the expression of CD69 or CD62L in cells
gated to CD4 or CD81CD45.11 population (IL-2Rb2/2–derived T
cells); thin lines represent that in cells gated to the CD4 or
CD81CD45.12 population (IL-2Rb1/1–derived T cells).1566 Normal T Cells Eliminate Activated IL-2Rb2/2 T Cells
which were prepared from normal B6 (IL-2Rb1/1) mice
and IL-2Rb2/2 mice, were mixed in equal numbers and
transferred to B6.RAG-22/2 host mice. 7 d later, B6-
derived T cells were recovered and purified by sorting cells
stained with anti-CD45.2 and anti-CD4/CD8 antibodies,
and the expressions of IL-2, IL-4, IFN-g, TNF-a, TNF-b,
FasL, granzyme B, and perforin were analyzed by the re-
verse transcription PCR method. The expression in T cells
Figure 3. Elimination of activated IL-2Rb2/2 T
cells by IL-2Rb1/1 T cells. T cells isolated from
IL-2Rb2/2 (CD45.11) or IL-2Rb1/1 (CD45.21)
mice by passing through a nylon wool column
were stained with FITC-conjugated anti-CD4 plus
PE-conjugated anti-CD8 antibodies, and analyzed
(top left and top right). T cells from two different
types of mice were mixed and checked for their
contents by staining with FITC-conjugated anti-
CD45.2 plus biotin-conjugated anti-CD45.1,
which was visualized by the secondary staining with
streptavidin-conjugated RED670 (top middle). IL-
2Rb1/1 T cells alone (lower left), IL-2Rb2/2 T
cells alone (lower right), or their mixture (lower
middle) were injected into B6.RAG-22/2 mice. 7 d
later, lymph node cells were analyzed for their
CD45 allotype markers (middle row) and for their
CD4/CD8 ratio (bottom row). Cells recovered
from mice transferred with a mixture of IL-2Rb1/1
and IL-2Rb2/2 were triple stained with anti-CD4,
anti-CD8, and anti-CD45.2 antibodies, and CD4/
CD8 expression in cells gated to CD45.21 (IL-
2Rb1/1) was shown (bottom middle). Numbers in
the panels represent percentages of cells in the indi-
cated quadrants.
Figure 4. Time course of elimination of IL-2Rb2/2 T cells cotransferred with IL-2Rb1/1 T cells. B6.RAG-22/2 mice were transferred with mixtures
of IL-2Rb1/1 (CD45.12) and IL-2Rb2/2 (CD45.11) T cells, and analyzed at the indicated time after T cell transfer. (A) Representative flow cytometric
profiles. Total cells recovered from spleen and lymph nodes were stained with anti-CD45.1 and anti–Thy-1.2 antibodies. Numbers in the panels repre-
sent percentages of cells in the indicated quadrant per total Thy-1.21 cells. (B) Data obtained from a total of 12 mice, including 3 independent mice ana-
lyzed at the same time point, are demonstrated. Open squares represent percentages of IL-2Rb1/1 cells per total Thy-1.21 cells recovered, and filled cir-
cles represent percentages of IL-2Rb2/2 cells per total Thy-1.21 cells. Data are represented by the mean value of three independent mice analyzed, and
their SD by error bars.1567 Suzuki et al.
recovered from mice transferred with IL-2Rb2/2 T cells
was compared with that in T cells simply transferred with-
out IL-2Rb2/2 T cells and recovered. As shown in Fig. 6
A, recovered T cells expressed all the genes tested, includ-
ing TNF-a, TNF-b, FasL, granzyme B, and perforin.
Among these, the expression levels of TNFs, especially
TNF-b, were higher in cells transferred with IL-2Rb2/2 T
cells (Fig. 6 B). These results indicated the possibility that
normal T cells eliminated IL-2Rb2/2 T cells by using these
molecules associated with T cell cytotoxic activity.
Discussion
Demonstration That Regulatory T Cells Are Strictly IL-2Rb
Dependent in Eliminating Activated T Cells. It was surpris-
ing to find that a disruption of one of the components of
the IL-2/IL-2 receptor system caused a significant activa-
tion and increase of T cells (8, 9, 14–16). This finding
proved that the IL-2/IL-2R system is important for regu-
lating and maintaining the homeostasis of immune systems,
although the precise mechanism of such regulation was not
clarified. Studies on IL-2–deficient and IL-2Ra–deficient
mice have demonstrated some insights into the possible
mechanism. T cells in IL-2–deficient mice were shown to
be more resistant to apoptosis induced by reactivation or
Fas triggering (11). IL-2Ra–deficient T cells were also
shown to be apoptosis resistant (12, 17). This failure of
spontaneous death may be a possible mechanism explaining
the expansion of abnormally activated T cells under the
condition in which IL-2 or IL-2R never functions. How-
ever, studies on IL-2Rb–deficient mice revealed that T
cells in these mice were normally sensitive to Fas-mediated
or superantigen-induced cell death (13). This finding indi-
cated the existence of another essential mechanism causing
the accumulation of abnormally activated T cells in IL-
2Rb–deficient mice.
In this study, we have demonstrated by two different ex-
perimental systems that normal T cells regulate the abnor-
mal activation of IL-2Rb2/2 T cells. Our experimental re-
sult of bone marrow transplantation appears to be a
“prevention of abnormal activation,” while that of T cell
transfer seems more like an “elimination of already acti-
vated cells,” possibly demonstrating that two different
mechanisms are involved in regulating abnormal T cells.
However, these two experiments showed some coinciden-
tal results: (a) lack of Fas or FasL molecules does not affect
regulatory activity; (b) cells with transgenic TCR lack reg-
ulatory activity; and (c) CD81 cells from IL-2Rb1/1 mice
are increased when they regulate IL-2Rb2/2 T cells. These
coincidences may indicate that the two experimental sys-
tems reflected the same event, and it would only be logical
to consider that a common mechanism worked to express
two different-looking phenomena. Based on this assump-
tion, the suppression of activation observed in bone mar-
row–transplanted mice could be maintained by continuous
elimination of activated T cells. Depletion of T cells lack-
ing IL-2Rb, observed in the T cell transfer experiment, is
not due to mere “general weakness” of those cells com-
pared with normal IL-2Rb1 T cells, because IL-2Rb2/2 T
cells, although their number is slightly reduced, do coexist
with IL-2Rb1 T cells in the mixed bone marrow chimeric
mice, and do not decrease when transferred with TCR
transgenic T cells. Therefore, lack of IL-2Rb itself cannot
trigger the elimination; however, some sign of the acti-
vated state could do so.
Krämer et al. also performed a study of mixed bone mar-
Figure 5. Fas–FasL-indepen-
dent and more effective elimina-
tion of IL-2Rb2/2 T cells by
CD81 cells. B6.RAG-22/2 mice
were transferred with 1:1 mix-
tures of IL-2Rb2/2 T cells and
T cells from B6, B6lpr/lpr, B6gld/gld,
or TCR transgenic (tg) mice
with RAG-22/2 background.
CD41 cells and CD81 cells were
obtained from normal B6 mice
using biotin-conjugated anti-
CD4 or anti-CD8 antibody and
streptavidin microbeads (MACS),
then mixed with IL-2Rb2/2 T
cells (1:1) and transferred to
B6.RAG-22/2 mice. 7 d later,
spleen and lymph node cells
were recovered and analyzed by
antibody staining and flow cy-
tometry. The total number of T
cells of indicated origin was cal-
culated as follows: (total number
of cells recovered from spleen
and lymph nodes) 3 (percentage
of T cells bearing the CD45 allotype marker). Three independent experiments including two recipient mice for each experiment were performed for
each combination of transfer, and the data are represented by mean percentages of recovered cell numbers per transferred cell numbers for indicated T
cell types, and their SD with error bars (n 5 6). *Significantly different (t test, P , 0.05); **significantly different (P , 0.01).1568 Normal T Cells Eliminate Activated IL-2Rb2/2 T Cells
row transplantation using IL-2–deficient mice, and found
that IL-22/2–derived T cells did not develop into an ab-
normal state in mixed chimera containing 30% IL-21 lym-
phocytes (18). Although their finding is similar to our
observation in mixed bone marrow chimera of IL-2Rb2/2
and IL-2Rb1 cells, it is unclear whether the same mecha-
nism works for the normalization of mutant T cells in the
mixed bone marrow transplantation system of IL-22/2and
that of IL-2Rb2/2, because no information, such as the de-
tailed distribution of the lymphocyte population in IL-22/2
mixed bone marrow chimera and the result of the mixed T
cell transfer experiment for IL-22/2, is provided. Further-
more, in the case of the IL-22/2 system, because IL-2
could be secreted from normal T cells and act on IL-22/2
T cells, it is impossible to identify whether the normalizing
mechanism is a paracrine action of IL-2, or the regulatory
activity of wild-type T cells. In our case, because IL-2
could never act on receptor-deficient T cells, a regulatory
mechanism other than the action of IL-2 on the activated
T cells must be working between normal T cells and IL-
2Rb–deficient T cells. By adding the system of the T cell
transfer experiment, we have postulated the mechanism to
be the elimination of activated T cells.
Recognition and Effector Molecules of the Regulatory T Cells.
The experiment using TCR transgenic mice showed a co-
incidental result in bone marrow transplantation and T cell
transfer. T cells with transgenic TCR showed no activity to
regulate activated IL-2Rb2/2 T cells. This result may indi-
cate that a/b-type functional TCR is directly involved in
the process of regulation and/or elimination as the recogni-
tion molecule on the regulatory T cells. However, it is also
possible that T cells in TCR transgenic mice are function-
ally monotonous, and may not include the regulatory T cell
population. A significant increase in Vb12 TCR–using cells
in CD81 T cells that had eliminated IL-2Rb2/2 T cells in
mixed T cell transferred mice (our unpublished observa-
tions) may indicate that CD81 T cells bearing Vb12 TCR
are the key population responding to IL-2Rb2/2 T cells.
However, the increase in Vb121 T cells is still small (con-
trol 5 1.92 6 0.10% vs. posttransfer 5 3.20 6 0.40%, n 5
3; P , 0.01), suggesting that the responsible T cells are
more likely to be multiclonal.
Figure 6. Expression of genes involved in T cell cytotoxic activity. (A) T cells from normal B6 (IL-
2Rb1/1) mice were either unmixed (single) or mixed (mixed) with T cells from IL-2Rb2/2 mice, and
were transferred to B6.RAG-22/2 host mice. 7 d later, B6 mice–derived T cells (CD45.21CD4 or
CD81) were recovered using a cell sorter (EPICS elite; Coulter), and RNA was extracted. After cDNA
was synthesized from each RNA sample, PCR was performed using primers described in Materials and
Methods to amplify the specific gene products. PCR products were run in 1.5% agarose gel containing
0.5 mg/ml ethidium bromide. The intensity of bands was analyzed using the Molecular Analyst pro-
gram (Bio-Rad). Numbers (right) indicate relative intensity of bands of mixed (T cells transferred with
IL-2Rb2/2 T cells) compared with single (T cells transferred alone, without IL-2Rb2/2 T cells). (B)
Increase of each gene expression (shown as a percentage) adjusted with that of b-actin was calculated as
follows: (relative band intensity of indicated gene of mixed compared with single) / (relative band in-
tensity of b-actin of mixed compared with single) 3 100. Three independent experiments (one recipi-
ent mouse per experiment) were performed, and the data are represented by mean values and their SD
with error bars. *Significantly different compared with b-actin (paired two group t test, P , 0.01);
**significantly different (P , 0.001).1569 Suzuki et al.
What molecules are involved in the process for the regu-
latory cells to recognize abnormally activated T cells re-
mains an important question. They could be T cell activa-
tion–linked molecules potentially presented to the regulatory
cells by the activated cells. IL-2Rb2/2 T cells express in-
creased levels of many cytokines, including IL-2, IL-4,
IL-10, IFN-g, TNF-a, and TGF-b (13; our unpublished
observations), and cell surface molecules such as CD69 and
CD44. These molecules could be working for recognition
by the regulatory T cells.
The additional question arises as to what molecules are
working in the effector phase. We performed an analysis of
the expression of several genes which may possibly be in-
volved in the effector phase of cytotoxic T cells (19, 20). A
Fas–FasL deficiency causes expansion of T cells and au-
toimmune-like abnormalities, suggesting a possible in-
volvement of this system in the regulation of activated T
cells (21). Although FasL expression was clearly identified
in the T cells eliminating IL-2Rb2/2 T cells (Fig. 6), our
study proved that Fas and FasL interaction was not indis-
pensable in the regulation and/or elimination of IL-2Rb–
deficient T cells (Fig. 5). Similarly, expression of TNFs,
perforin, and granzyme B was observed, and the level of
TNF-b expression was elevated in T cells eliminating IL-
2Rb2/2 T cells. Mice lacking the activity of TNFs, per-
forin, or granzyme B molecules show no sign of an increase
in activated T cells (22–24), suggesting that the defect of a
single molecule may be indecisive in the regulatory activ-
ity. Taken together, these molecules involved in the cyto-
toxic T cell function may compensate for one another, and
IL-2Rb may be the key molecule controlling the central
function or development of cells using these molecules.
Cell Surface Phenotypes of Regulatory T Cells. Our study
indicated that CD81 cells are more effective regulators
against the activated IL-2Rb2/2 T cells. The regulatory
cells found in this study may be related to the suppressor
T cell subsets that have been described in previous reports.
Both CD81 and CD41 subsets were reported to include
suppressor T cells (25–27), and the suppressor activity is
sometimes related to Fas–FasL dependency (28). In our
study, however, the regulatory activity is stronger in
CD81 cells than in CD41 cells, and Fas–FasL independent.
CD41 cells alone are also sufficient to achieve the regula-
tory activity (Fig. 5), indicating the heterogeneity of the re-
sponsible cells. This elimination by CD41 cells is not due
to any minor contamination of CD81 cells, ,5% of which
remain after purification with anti-CD8 antibody and
MACS, because a small number of CD81 T cells (one
tenth of IL-2Rb2/2 cells) is not sufficient to eliminate IL-
2Rb2/2 T cells (data not shown).
The “regulatory T cells” described in more recent stud-
ies seem to expand to both the CD41 and CD81 popula-
tions (29–35), indicating that a variety of cells perform the
immunoregulatory activity. CD41 regulatory cells de-
scribed in several studies constitutively express CD25 (IL-
2Ra [36–40]). These CD251CD41 regulatory cells sup-
press the IL-2 production from CD41CD252 cells, and
only respond to a high dose of IL-2. CD381CD41 regula-
tory cells proliferate when subject to TCR stimulation in
the presence of IL-2 (41). Although the cell surface pheno-
types are varied, these findings of IL-2R expression and re-
sponsiveness to IL-2 may agree with our data, further indi-
cating the importance of the IL-2/IL-2R system in the
regulation of T cell activity. The importance of the regula-
tory T cells found in our analysis is that they have the activ-
ity to eliminate abnormally activated T cells. Such elimina-
tion activity has not been reported in the majority of
previously described regulatory T cells, except CD81 regu-
latory T cells, which were shown to eliminate activated
Vb81CD41 cells in a Qa-1–restricted manner (42). The
elimination of activated IL-2Rb2/2 T cells may be related
to cytotoxic activity, because such elimination is related to
CD81 population, and the eliminating cells express mole-
cules related to the cytotoxic effector function. Further
characterization and purification of the T cells regulating
IL-2Rb2/2 cells by the in vitro culture system may estab-
lish the mechanism of this elimination process.
In this study, we investigated the relationship between
IL-2Rb2/2 T cells and normal T cells, and found a mecha-
nism by which normal T cells could regulate activated IL-
2Rb2/2 T cells. We propose that IL-2Rb is essential for
the development of the regulatory TCR-a/b T cells that
effectively eliminate activated T cells. Lack of such regula-
tory activity may result in an accumulation of activated T
cells such as those observed in IL-2Rb–deficient mice.
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